Summary
Inactivation of GABA was inhibited by γ-vinyl GABA (GVG) and the effects of the increased GABA level in the brain on blood pressure and body weight of spontaneously hypertensive rats (SHR) and normotensive rats (WKY) were investigated.
When started at the age of 8 weeks or 5 weeks, treatment of SHR and WKY with GVG (150 mg/kg, s.c.) for several weeks did not influence systolic blood pressure. In 1-week old SHR, treatment with GVG (up to 150 mg/kg, s.c.) abolished the rise in blood pressure until animals were 8 weeks old. Thereafter, arterial blood pressure started to increase but it remained distinctly lower than that in untreated animals. When started at the age of 1 week, treatment with GVG for 7 weeks did not influence arterial blood pressure in WKY. GVG delayed increase in body weight in SHR and WKY, irrespective of their age. GVG greatly increased GABA levels in the hypothalamus, frontal cortex, brainstem and rest of the brain in both WKY and SHR.
It is concluded that an increase in the GABA level in the brain leads to a delay in the development of hypertension in young SHR. Hence, development of genetic hypertension seems to be susceptible to activation of the GABAergic system in a very early critical phase only.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdul-Ghani AS, Coutinho-Netto J, Bradford HF (1980) The acting of γ-vinyl-GABA and γ-acetylenic-GABA on the resting and stimulated release of GABA in vivo. Brain Res 191:471–481
Antonaccio MJ, Taylor DG (1977) Involvement of central GABA receptors in the regulation of blood pressure and heart rate of anaesthetized cats. Eur J Pharmacol 46:283–287
Bedwani JS, Mehta A (1987) Effects of the γ-aminobutyrate transaminase inhibitors gabaculine and γ-vinyl GABA on γ-aminobutyric acid release from slices of rat cerebral cortex. Neurochem Res. 12:49–52
Bhargava KP, Bhattacharya SS, Srimal RC (1964) Central cardiovascular actions of γ-aminobutyric acid. Br J Pharmacol 23:383–390
Biswas B, Carlsson A (1977) The effect of intracerebroventricularly administered GABA on brain monoamine metabolism. Naunyn-Schmiedeberg's Arch Pharmacol 299:41–46
Bousquest P, Feldman J, Bloch R, Schwartz J (1984) Pharmacological analysis of the central cardiovascular effects of four GABA analogues. Naunyn-Schmiedeberg's Arch Pharmacol 325: 291–297
Catelli JM, Giakas WJ, Sved AF (1987) GABAergic mechanisms in nucleus tractus solitarius alter blood pressure and vasopressin release. Brain Res 403:279–289
Cooper BR, Howard JL, White HL, Soroko F, Ingold K, Maxwell RA (1980) Anorexic effects of ethanolamine-0-sulfate and muscimol in the rat: evidence that GABA inhibits ingestive behavior. Life Sci 26:1997–2002
Elliott KAC, Hobbiger F (1959) γ-Aminobutyric-acid: circulatory and respiratory effects in different species; re-investigation of the anti-strychnine action in mice. J Physiol (Lond) 146:70–84
Glowinski J, Iversen LL (1966) Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem 13:655–669
Gram L, Larsson OM, Johnsen, AH, Schousboe A (1988) Effects of valproate, vigabatrin and aminooxyacetic acid on release of endogenous and exogenous GABA from cultures neurons. Epilepsy Res 2:87–95
Grove J. Gardner CR, Richards MH (1982) Measurement of release of endogenous GABA and catabolites of [3H]GABA from synaptosomal preparations using ion-exchange chromatography. Neurochem Res 7:589–599
Hambley JW, Johnston GAR, Shaw J (1984) Alterations in a hypothalamic GABA system in the spontaneously hypertensive rat. Neurochem Int 6:813–821
Harrap SB, Van der Merwe WM, Griffin SA (1990) Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertention 16:603–614
Huot S, Palfreyman MG (1982) Effects of γ-vinyl GABA on food intake of rats. Pharmacol Biochem Behav 17:99–106
Jung MJ, Lippert B, Metcalf BW, Böhlen P, Schechter PJ (1977) γ-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice. J Neurochem 29:797–802
Klausmair A, Philippu A (1989) Carotid occlusion increases the release of endogenous GABA in the nucleus of the solitary tract. Naunyn-Schmiedeberg's Arch Pharmacol 340:764–766
Kubo T, Kihara M (1987) Evidence for the presence of GABAergic and glycine-like systems responsible for cardiovascular control in the nucleus tractus solitarii of the rat. Neurosci Lett 74:331–336
Lippert B, Metcalf BW, Jung MJ, Casara P (1977) 4-Amino-hex-5-enoic acid, a selective catalaytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain. Eur J Biochem 74:441–445
Löscher W (1981) Relationship between drug-induced changes in seizure thresholds and the GABA content of brain and brain nerve endings. Naunyn-Schmiedeberg's Arch Pharmacol 317:131–134
Löscher W (1982) Cardiovascular effects of GABA, GABA-aminotransferase inhibitors and valproic acid following systemic administration in rats, cats and dogs: pharmacological approach to localize the site of action. Arch Int Pharmacodyn 257:32–58
Neal MJ and Shah MA (1990) Development of tolerance to the effects of vigabatrin (γ-vinyl-GABA) on GABA release from rat cerebral cortex, spinal cord and retina. Br J Pharmacol 100:324–328
Okada Y, Nitsch-Hassler C, Kim JS, Bak IJ, Hassler R (1971) Role of γ-aminobutyric acid (GABA) in the extrapyramidal motor system. I. Regional distribution of GABA in rabbit, rat, guinea pig and baboon CNS. Exp Brain Res 13:514–518
Olgiati VR, Netti C, Guidobond F (1980) The central GABAergic system and control of food intake under different experimental conditions. Psychopharmacology 68:163–167
Persson B, Henning M (1980) Effect of GABA analogues on blood pressure and central GABA metabolism in the rat. Acta Pharmacol Toxicol 47:135–143
Philippu A, Przuntek H, Roensberg W (1973) Superfusion of the hypothalamus with γ-aminobutyric acid: effect on release of noradrenaline and blood pressure. Naunyn-Schmiedeberg's Arch Pharmacol 276:103–118
Philippu A (1988) Regulation of blood pressure by central neurotransmitters and neuropeptides. Rev Physiol Biochem Pharmacol 111:1–115
Schechter PJ, Tranier Y, Jung MJ, Böhlen P (1977) Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of γ-acetylenic GABA and γ-vinyl GABA, two irreversible GABA-T inhibitors. Eur J Pharmacol 45:319–328
Sved AF, Sved JC (1990) Endogenous GABA acts on GABAB recpetors in nucleus tractus solitarius to increase blood pressure. Brain Res 526:235–240
Tuomisto L, Yamatodani A, Died H, Waldmann U, Philippu A (1983) In vivo release of endogenous catecholamines, histamine and GABA in the hypothalamus of Wistar Kyoto and spontaneously hypertensive rats. Naunyn-Schmiedeberg's Arch Pharmacol 323:183–187
Winne D (1965) Zur Auswertung von Versuchsergebnissen: Die Prüfung, ob Kurven sich in ihrem Verlauf unterscheiden. Naunyn-Schmiedeberg's Arch Exp Pathol Pharmakol 250:383–396
Yang CP, Lin MT (1983) Amino acids injected into the cerebroventricular system induce an enhancement of reflex bradycardia in the rat. Neuropharmacology 22:1190–1193
Author information
Authors and Affiliations
Additional information
Send offprint requests to N. Singewald at the above address
This work was supported by the Fonds zur Förderung der wissenschaftlichen Forschung
Rights and permissions
About this article
Cite this article
Singewald, N., Pfitscher, A. & Philippu, A. Effects of gamma-vinyl GABA (vigabatrin) on blood pressure and body weight of hypertensive and normotensive rats. Naunyn-Schmiedeberg's Arch Pharmacol 345, 181–186 (1992). https://doi.org/10.1007/BF00165734
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00165734